Results 151 to 160 of about 682,686 (266)

Age‐Associated Four‐Gene Prognostic Signature in Breast Cancer

open access: yesCancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Young‐onset breast cancer is associated with inferior disease‐free survival (DFS), but the contribution of additional molecular heterogeneity remains unclear. Aims To identify an exploratory age‐associated gene expression signature linked to recurrence‐related outcomes and evaluate its prognostic association.
Shiro Uchida
wiley   +1 more source

Simultaneous occurrence of papillary thyroid carcinoma, medullary thyroid carcinoma, and lymphoma: A case report. [PDF]

open access: yesMedicine (Baltimore)
Hao Z   +8 more
europepmc   +1 more source

Cancer‐related pain: A bidirectional modulator of cancer progression

open access: yesClinical and Translational Medicine, Volume 16, Issue 9, September 2026.
CRP and tumour progression engage in a dynamic, bidirectional circuit mediated by multiple mechanisms involving neuroimmunology and cancer ‐neuroscience. Analgesic interventions may affect tumour progression, while anticancer therapies can influence pain. Targeting pain in cancer may have promising therapeutic value in cancer progression.
Junzhe He   +5 more
wiley   +1 more source

Medullary Carcinoma of the Ascending Colon in an Older Woman: A Case Report. [PDF]

open access: yesSurg Case Rep
Kishimoto A   +8 more
europepmc   +1 more source

RET Proto-Oncogene Mutation in Medullary Thyroid Carcinoma

open access: yes, 2002
Background: The molecular pathogenesis of hereditary medullary thyroid carcinoma is well known to be associated with germ-line mutation in the RET proto-oncogene and sporadic medullary thyroid carcinoma has been shown to carry somatic RET mutation ...
조남훈
core  

Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
Tirzepatide and SGLT2 inhibitors act through distinct but complementary mechanisms in obesity‐related HFpEF: tirzepatide targets adiposity, inflammation, and insulin resistance, while SGLT2 inhibitors improve decongestion, myocardial energetics, and cardiac remodeling.
Zakariye Isak Mohamed   +8 more
wiley   +1 more source

Preoperative Metyrosine Administration for Bilateral Pheochromocytomas Following Pheochromocytoma Crisis: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 5, September 2026.
ABSTRACT Introduction Pheochromocytoma crisis complicated by catecholamine‐induced cardiomyopathy is a life‐threatening condition requiring careful preoperative management. Although metyrosine has recently been approved in Japan for the perioperative management of pheochromocytoma, clinical experience remains limited.
Nanaho Demizu   +9 more
wiley   +1 more source

The Evolution of Medications for Obesity Management

open access: yesJGH Open, Volume 10, Issue 9, September 2026.
ABSTRACT This narrative review provides an overview of progress in the development of obesity medications, including a synthesis of data describing the efficacy and safety of currently available agents and emerging therapeutic options. Historically, many obesity medications have been withdrawn from the market due to safety concerns.
Jaskirath Gill, Priya Sumithran
wiley   +1 more source

Synchronous medullary carcinoma of the pancreas and non-ampullary duodenal adenocarcinoma. [PDF]

open access: yesArch Clin Cases
D'Avila L   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy